ArticleJournal of diabetes investigation2019

Safety and tolerability of empagliflozin in East Asian patients with type 2 diabetes: Pooled analysis of phase I-III clinical trials.

Daisuke Yabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.